臓器保存市場：2027年までの予測

出版：Market Research Future（マーケットリサーチフューチャー）　出版年月：2022年05月

臓器保存市場：臓器保存市場：ソリューション（UW、保管HTK、コリンズソリューション、セルシオソリューション、Perfadex、クエン酸塩ソリューション）、保存技術（固定冷蔵、機能的冷蔵）、臓器タイプ（腎臓、肝臓、心臓、肺、その他）、エンドユーザー別（病院、診療所、臓器バンクなど）、地域別（アメリカ、ヨーロッパ、アジア太平洋、中東＆アフリカ）- 2027年までの予測

Organ Preservation Market: Information by Solution (University of Wisconsin Solution, Custodial HTK, Collins Solution, Celsior Solution, Perfadex, Citrate Solution), by Preservation Techniques (Static Cold Storage and Dynamic Cold Storage), by Organ Type (Kidney, Liver, Heart, Lungs, Others), by End User (Hospitals & Clinics, Organ Banks, and Others.) and by Region (Americas, Europe, Asia-Pacific, Middle East & Africa)—Forecast till 2027

レポート目次　　　　お問合せ・ご注文　　　　価格・納期について

Organ Preservation Market—Forecast till 2027

Market Overview

As per the MRFR analysis, the global organ preservation market is anticipated to witness a healthy market expansion of 6.48% during the review period to surpass USD 304.68 million by the end of 2027.
Organ preservation is the stock line for organ transplantation. At present, the pancreas, liver, and kidney can be safeguarded for as long as two days by flushing the organs with the University of Wisconsin (UW) organ preservation arrangement as well as putting away them at hypothermia (0-5 degrees C). The UW arrangement is viable in the light of the fact that it utilized a few cell impermeant specialists like raffinose, lactobionic corrosive, and hydroxyethyl starch which decrease the phones from aggravation during cold ischemic stockpiling. The rising number of organ relocation techniques goes about as a significant driver in the worldwide organ preservation market from 2021 to 2027. In any case, the significant expense related to organ transplantation hampers the development of the organ preservation market during the gauge time frame. Expanding government drives connected with organ transfers and organ gifts are supposed to set out freedom in the worldwide organ preservation market.

Segment Overview
The global organ preservation market is categorized among solution, preservation techniques, organ type, and end-user.
The Solution segment is further classified into the University of Wisconsin Solution, Custodial HTK, Collins Solution, Celsior Solution, Perfadex, and Citrate Solution.
The preservation techniques segment is divided into static cold storage and dynamic cold storage. Dynamic cold storage is further divided into hypothermic machine perfusion, normothermic machine perfusion, and oxygen per sufflation.
Based on the organ type, the market is divided into heart, kidney, lungs, liver, and others. The end-user segment divides the market into organ banks, hospitals & clinics, and others.
Regional Analysis
The Americas is likely to lead the global organ preservation market owing to the largest market share of 45.7% during the review period. The regional market growth is attributed to the growing number of organ transplant procedures, growing incidences of multiple organ failure, and rising geriatric failure. Americas is classified into North America and Latin America. The North American market is spread across the US and Canada.
Europe is the second-biggest market and holds a solid offer in the worldwide organ protection market. The European market is supposed to develop at a tough rate during the conjecture time frame because of cutting-edge treatment offices and rising instances of greasy liver sickness.
Asia-Pacific is assessed to be the quickest developing business sector attributable to the creation of medical care foundations and expanding extra cash in agricultural nations like China and India. The Middle East and Africa is supposed to observe consistent development because of an absence of mindfulness with respect to organ gift, restricted admittance, and the exorbitance of treatment offices among the populace.
Major Players
The prominent players operating in the global organ preservation are TransMedics Group, Inc (US), Inc (US), Shanghai Genext Medical Technology Co., Ltd (China), 21st Century Medicine (US), Bristol Myers Squibb (US), Artivion, Inc (US), BioLife Solutions, Paragonix Technologies Inc (US), Xvivo Perfusion AB (US), Accord Healthcare Limited (UK), Franz Köhler Chemie GmbH (Germany), and Waters Medical Systems (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

目次

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 16

1.1 MARKET SYNOPSIS 16

2 MARKET INTRODUCTION 17

2.1 SCOPE OF THE STUDY 17

2.2 RESEARCH OBJECTIVE 17

2.3 LIST OF ASSUMPTIONS & LIMITATIONS 17

3 RESEARCH METHODOLOGY 19

3.1 DATA MINING 19

3.2 SECONDARY RESEARCH 20

3.3 PRIMARY RESEARCH 21

3.3.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 21

3.3.2 BREAKDOWN OF PRIMARY RESPONDENTS 22

3.4 FORECASTING TECHNIQUES 22

3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 23

3.5.1 BOTTOM-UP APPROACH 24

3.5.2 TOP-DOWN APPROACH 25

3.6 DATA TRIANGULATION 25

3.7 VALIDATION 25

4 MARKET DYNAMICS 26

4.1 OVERVIEW 26

4.2 DRIVERS 27

4.2.1 INCREASING FOCUS OF ORGAN PRESERVATION COMPANIES ON BRAND PROTECTION 27

4.2.2 RISING NUMBER OF ORGAN TRANSPLANT PROCEDURES 27

4.2.3 RISING INSTANCES OF MULTIPLE ORGAN FAILURE 27

4.3 RESTRAINT 28

4.3.1 HIGH COST ASSOCIATED WITH ORGAN TRANSPLANTATION 28

4.4 OPPORTUNITY 29

4.4.1 INCREASING GOVERNMENT INITIATIVES RELATED TO ORGAN TRANSPLANT AND ORGAN DONATION 29

5 MARKET FACTOR ANALYSIS 30

5.1 VALUE CHAIN ANALYSIS 30

5.1.1 R&D 31

5.1.2 MANUFACTURING 31

5.1.3 DISTRIBUTION AND SALES 31

5.1.4 POST-SALES MONITORING 31

5.2 PORTER’S FIVE FORCES MODEL 32

5.2.1 BARGAINING POWER OF SUPPLIERS 32

5.2.2 BARGAINING POWER OF BUYERS 33

5.2.3 THREAT OF NEW ENTRANTS 33

5.2.4 THREAT OF SUBSTITUTES 33

5.2.5 INTENSITY OF RIVALRY 33

5.3 IMPACT OF COVID-19 ON ORGAN PRESERVATION MARKET 33

5.3.1 OVERVIEW 33

5.3.2 IMPACT ON SUPPLY CHAIN 33

5.3.3 IMPACT ON DEMAND FOR ORGAN PRESERVATION SOLUTIONS 34

6 GLOBAL ORGAN PRESERVATION MARKET, BY SOLUTION 35

6.1 OVERVIEW 35

6.2 UNIVERSITY OF WISCONSIN SOLUTION 36

6.3 CUSTODIOL HTK 36

6.4 COLLINS SOLUTION 37

6.5 CELSIOR SOLUTION 38

6.6 PERFADEX 39

6.7 CITRATE SOLUTION 40

7 GLOBAL ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES 41

7.1 OVERVIEW 41

7.2 STATIC COLD STORAGE (SCS) TECHNIQUE 42

7.3 DYNAMIC COLD STORAGE 42

7.3.1 HYPOTHERMIC MACHINE PERFUSION 43

7.3.2 NORMOTHERMIC MACHINE PERFUSION 44

7.3.3 OXYGEN PERSUFFLATION 44

8 GLOBAL ORGAN PRESERVATION MARKET, BY ORGAN TYPE 45

8.1 OVERVIEW 45

8.2 KIDNEY 46

8.3 LIVER 46

8.4 HEART 47

8.5 LUNGS 48

8.6 OTHERS 48

9 GLOBAL ORGAN PRESERVATION MARKET, BY END USER 49

9.1 OVERVIEW 49

9.2 HOSPITALS & CLINICS 50

9.3 ORGAN BANKS 50

9.4 OTHERS 51

10 GLOBAL ORGAN PRESERVATION MARKET, BY REGION 52

10.1 OVERVIEW 52

10.2 AMERICAS 54

10.2.1 NORTH AMERICA 57

10.2.1.1 US 59

10.2.1.2 CANADA 61

10.2.2 LATIN AMERICA 63

10.3 EUROPE 65

10.3.1 WESTERN EUROPE 67

10.3.1.1 SPAIN 70

10.3.1.2 FRANCE 71

10.3.1.3 UK 73

10.3.1.4 ITALY 75

10.3.1.5 GERMANY 76

10.3.1.6 REST OF WESTERN EUROPE 78

10.3.2 EASTERN EUROPE 80

10.4 ASIA PACIFIC 82

10.4.1 CHINA 85

10.4.2 INDIA 86

10.4.3 AUSTRALIA 88

10.4.4 SOUTH KOREA 90

10.4.5 JAPAN 91

10.4.6 REST OF ASIA PACIFIC 93

10.5 MIDDLE EAST & AFRICA 95

10.5.1 MIDDLE EAST 97

10.5.2 AFRICA 99

11 COMPETITIVE LANDSCAPE 101

11.1 OVERVIEW 101

11.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ORGAN PRESERVATION

MARKET 104

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 105

11.6.1 PRODUCT APPROVAL 105

11.6.2 ACQUISITION 105

11.6.3 PRODUCT LAUNCH 106

11.7 MAJOR PLAYERS FINANCIAL MATRIX 106

11.7.1 SALES (USD MILLION), 2020 106

11.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2020 106

12 COMPANY PROFILES 107

12.1 TRANSMEDICS GROUP, INC. 107

12.1.1 COMPANY OVERVIEW 107

12.1.2 FINANCIAL OVERVIEW 108

12.1.3 PRODUCTS/SERVICES OFFERED 108

12.1.4 KEY DEVELOPMENTS 109

12.1.5 SWOT ANALYSIS 109

12.1.6 KEY STRATEGIES 109

12.2 BRISTOL-MYERS SQUIBB COMPANY 110

12.2.1 COMPANY OVERVIEW 110

12.2.2 FINANCIAL OVERVIEW 110

12.2.3 PRODUCTS/SERVICES OFFERED 111

12.2.4 KEY DEVELOPMENTS 111

12.2.5 SWOT ANALYSIS 111

12.2.6 KEY STRATEGIES 111

12.3 CRYOLIFE, INC. 112

12.3.1 COMPANY OVERVIEW 112

12.3.2 FINANCIAL OVERVIEW 112

12.3.3 PRODUCTS/SERVICES OFFERED 113

12.3.4 KEY DEVELOPMENTS 113

12.3.5 SWOT ANALYSIS 113

12.3.6 KEY STRATEGIES 113

12.4 XVIVO PERFUSION AB 114

12.4.1 COMPANY OVERVIEW 114

12.4.2 FINANCIAL OVERVIEW 114

12.4.3 PRODUCTS/SERVICES OFFERED 115

12.4.4 KEY DEVELOPMENTS 115

12.4.5 SWOT ANALYSIS 116

12.4.6 KEY STRATEGIES 116

12.5 ACCORD HEALTHCARE 117

12.5.1 COMPANY OVERVIEW 117

12.5.2 FINANCIAL OVERVIEW 117

12.5.3 PRODUCTS/SERVICES OFFERED 117

12.5.4 KEY DEVELOPMENTS 117

12.5.5 SWOT ANALYSIS 118

12.5.6 KEY STRATEGIES 118

12.6 DR. FRANZ KÖEHLER CHEMIE GMBH 119

12.6.1 COMPANY OVERVIEW 119

12.6.2 FINANCIAL OVERVIEW 119

12.6.3 PRODUCTS/SERVICES OFFERED 119

12.6.4 KEY DEVELOPMENTS 119

12.6.5 SWOT ANALYSIS 120

12.6.6 KEY STRATEGIES 120

12.7 21ST CENTURY MEDICINE 121

12.7.1 COMPANY OVERVIEW 121

12.7.2 FINANCIAL OVERVIEW 121

12.7.3 PRODUCTS/SERVICES OFFERED 121

12.7.4 KEY DEVELOPMENTS 121

12.7.5 SWOT ANALYSIS 122

12.7.6 KEY STRATEGIES 122

12.8 BIOLIFE SOLUTIONS INC 123

12.8.1 COMPANY OVERVIEW 123

12.8.2 FINANCIAL OVERVIEW 123

12.8.3 PRODUCTS/SERVICES OFFERED 124

12.8.4 KEY DEVELOPMENTS 124

12.8.5 SWOT ANALYSIS 125

12.8.6 KEY STRATEGIES 125

12.9 SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD 126

12.9.1 COMPANY OVERVIEW 126

12.9.2 FINANCIAL OVERVIEW 126

12.9.3 PRODUCTS/SERVICES OFFERED 126

12.9.4 KEY DEVELOPMENTS 126

12.9.5 SWOT ANALYSIS 127

12.9.6 KEY STRATEGIES 127

12.10 PARAGONIX TECHNOLOGIES, INC. 128

12.10.1 COMPANY OVERVIEW 128

12.10.2 FINANCIAL OVERVIEW 128

12.10.3 PRODUCTS/SERVICES OFFERED 128

12.10.4 KEY DEVELOPMENTS 128

12.10.5 SWOT ANALYSIS 129

12.10.6 KEY STRATEGIES 129

12.11 WATERS MEDICAL SYSTEMS 130

12.11.1 COMPANY OVERVIEW 130

12.11.2 FINANCIAL OVERVIEW 130

12.11.3 PRODUCTS/SERVICES OFFERED 130

12.11.4 KEY DEVELOPMENTS 130

12.11.5 SWOT ANALYSIS 131

12.11.6 KEY STRATEGIES 131

13 APPENDIX 132

13.1 REFERENCES 132

13.2 RELATED REPORTS 132
LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 17

TABLE 2 GLOBAL ORGAN PRESERVATION MARKET, BY SOLUTION, 2018–2027 (USD MILLION) 35

TABLE 3 GLOBAL ORGAN PRESERVATION MARKET, FOR UNIVERSITY OF WISCONSIN SOLUTION, BY REGION, 2018–2027 (USD MILLION) 36

TABLE 4 GLOBAL ORGAN PRESERVATION MARKET, FOR CUSTODIOL HTK, BY REGION, 2018–2027 (USD MILLION) 37

TABLE 5 GLOBAL ORGAN PRESERVATION MARKET, FOR COLLINS SOLUTION, BY REGION, 2018–2027 (USD MILLION) 37

TABLE 6 GLOBAL ORGAN PRESERVATION MARKET, FOR CELSIOR SOLUTION, BY REGION, 2018–2027 (USD MILLION) 38

TABLE 7 GLOBAL ORGAN PRESERVATION MARKET, FOR PERFADEX, BY REGION, 2018–2027 (USD MILLION) 39

TABLE 8 GLOBAL ORGAN PRESERVATION MARKET, FOR CITRATE SOLUTION, BY REGION, 2018–2027 (USD MILLION) 40

TABLE 9 GLOBAL: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018–2027 (USD MILLION) 41

TABLE 10 GLOBAL: ORGAN PRESERVATION MARKET FOR STATIC COLD STORAGE (SCS) TECHNIQUE, BY REGION,

2018–2027 (USD MILLION) 42

TABLE 11 GLOBAL: ORGAN PRESERVATION MARKET, FOR DYNAMIC COLD STORAGE, BY REGION, 2018–2027 (USD MILLION) 42

TABLE 12 GLOBAL: ORGAN PRESERVATION MARKET, FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES

2018–2027 (USD MILLION) 43

TABLE 13 GLOBAL: ORGAN PRESERVATION MARKET, FOR HYPOTHERMIC MACHINE PERFUSION, BY REGION, 2018–2027 (USD MILLION) 43

TABLE 14 GLOBAL: ORGAN PRESERVATION MARKET, FOR NORMOTHERMIC MACHINE PERFUSION, BY REGION,

2018–2027 (USD MILLION) 44

TABLE 15 GLOBAL: ORGAN PRESERVATION MARKET, FOR OXYGEN PERSUFFLATION, BY REGION, 2018–2027 (USD MILLION) 44

TABLE 16 GLOBAL: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018–2027 (USD MILLION) 45

TABLE 17 GLOBAL: ORGAN PRESERVATION MARKET FOR KIDNEY, BY REGION, 2018–2027 (USD MILLION) 46

TABLE 18 GLOBAL: ORGAN PRESERVATION MARKET, FOR LIVER, BY REGION, 2018–2027 (USD MILLION) 46

TABLE 19 GLOBAL: ORGAN PRESERVATION MARKET FOR HEART, BY REGION, 2018–2027 (USD MILLION) 47

TABLE 20 GLOBAL: ORGAN PRESERVATION MARKET, FOR LUNGS, BY REGION, 2018–2027 (USD MILLION) 48

TABLE 21 GLOBAL: ORGAN PRESERVATION MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION) 48

TABLE 22 GLOBAL: ORGAN PRESERVATION MARKET, BY END USER, 2018–2027 (USD MILLION) 49

TABLE 23 GLOBAL: ORGAN PRESERVATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2018–2027 (USD MILLION) 50

TABLE 24 GLOBAL: ORGAN PRESERVATION MARKET, FOR ORGAN BANKS, BY REGION, 2018–2027 (USD MILLION) 51

TABLE 25 GLOBAL: ORGAN PRESERVATION MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION) 51

TABLE 26 GLOBAL: ORGAN PRESERVATION MARKET, BY REGION, 2018–2027 (USD MILLION) 52

TABLE 27 AMERICAS: ORGAN PRESERVATION MARKET, BY REGION, 2018–2027 (USD MILLION) 54

TABLE 28 AMERICAS: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 55

TABLE 29 AMERICAS: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 55

TABLE 30 AMERICAS: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 55

TABLE 31 AMERICAS: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 56

TABLE 32 AMERICAS: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 56

TABLE 33 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 57

TABLE 34 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 58

TABLE 35 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 58

TABLE 36 NORTH AMERICA: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 58

TABLE 37 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 59

TABLE 38 NORTH AMERICA: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 59

TABLE 39 US: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 59

TABLE 40 US: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 60

TABLE 41 US: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 60

TABLE 42 US: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 60

TABLE 43 US: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 61

TABLE 44 CANADA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 61

TABLE 45 CANADA: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 61

TABLE 46 CANADA: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 62

TABLE 47 CANADA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 62

TABLE 48 CANADA: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 62

TABLE 49 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 63

TABLE 50 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 63

TABLE 51 LATIN AMERICA: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 64

TABLE 52 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 64

TABLE 53 LATIN AMERICA: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 64

TABLE 54 EUROPE: ORGAN PRESERVATION MARKET, BY REGION, 2018–2027 (USD MILLION) 65

TABLE 55 EUROPE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 66

TABLE 56 EUROPE: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 66

TABLE 57 EUROPE: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 66

TABLE 58 EUROPE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 67

TABLE 59 EUROPE: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 67

TABLE 60 WESTERN EUROPE: ORGAN PRESERVATION MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 67

TABLE 61 WESTERN EUROPE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 68

TABLE 62 WESTERN EUROPE: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 68

TABLE 63 WESTERN EUROPE: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 69

TABLE 64 WESTERN EUROPE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 69

TABLE 65 WESTERN EUROPE: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 69

TABLE 66 SPAIN: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 70

TABLE 67 SPAIN: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 70

TABLE 68 SPAIN: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 70

TABLE 69 SPAIN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 71

TABLE 70 SPAIN: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 71

TABLE 71 FRANCE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 71

TABLE 72 FRANCE: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 72

TABLE 73 FRANCE: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 72

TABLE 74 FRANCE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 72

TABLE 75 FRANCE: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 73

TABLE 76 UK: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 73

TABLE 77 UK: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 73

TABLE 78 UK: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 74

TABLE 79 UK: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 74

TABLE 80 UK: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 74

TABLE 81 ITALY: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 75

TABLE 82 ITALY: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 75

TABLE 83 ITALY: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 75

TABLE 84 ITALY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 76

TABLE 85 ITALY: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 76

TABLE 86 GERMANY: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 76

TABLE 87 GERMANY: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 77

TABLE 88 GERMANY: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 77

TABLE 89 GERMANY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 77

TABLE 90 GERMANY: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 78

TABLE 91 REST OF WESTERN EUROPE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 78

TABLE 92 REST OF WESTERN EUROPE: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 78

TABLE 93 REST OF WESTERN EUROPE: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION

TECHNIQUES, 2018-2027 (USD MILLION) 79

TABLE 94 REST OF WESTERN EUROPE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 79

TABLE 95 REST OF WESTERN EUROPE: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 79

TABLE 96 EASTERN EUROPE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 80

TABLE 97 EASTERN EUROPE: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 80

TABLE 98 EASTERN EUROPE: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 80

TABLE 99 EASTERN EUROPE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 81

TABLE 100 EASTERN EUROPE: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 81

TABLE 101 ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY COUNTRY, 2018–2027 (USD MILLION) 82

TABLE 102 ASIA-PACIFIC: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 83

TABLE 103 ASIA-PACIFIC: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 83

TABLE 104 ASIA-PACIFIC: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 84

TABLE 105 ASIA-PACIFIC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 84

TABLE 106 ASIA-PACIFIC: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 84

TABLE 107 CHINA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 85

TABLE 108 CHINA: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 85

TABLE 109 CHINA: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 85

TABLE 110 CHINA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 86

TABLE 111 CHINA: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 86

TABLE 112 INDIA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 86

TABLE 113 INDIA: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 87

TABLE 114 INDIA: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 87

TABLE 115 INDIA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 87

TABLE 116 INDIA: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 88

TABLE 117 AUSTRALIA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 88

TABLE 118 AUSTRALIA: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 88

TABLE 119 AUSTRALIA: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 89

TABLE 120 AUSTRALIA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 89

TABLE 121 AUSTRALIA: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 89

TABLE 122 SOUTH KOREA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 90

TABLE 123 SOUTH KOREA: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 90

TABLE 124 SOUTH KOREA: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 90

TABLE 125 SOUTH KOREA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 91

TABLE 126 SOUTH KOREA: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 91

TABLE 127 JAPAN: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 91

TABLE 128 JAPAN: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 92

TABLE 129 JAPAN: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 92

TABLE 130 JAPAN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 92

TABLE 131 JAPAN: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 93

TABLE 132 REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 93

TABLE 133 REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 93

TABLE 134 REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 94

TABLE 135 REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 94

TABLE 136 REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 94

TABLE 137 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY REGION, 2018–2027 (USD MILLION) 95

TABLE 138 MIDDLE EAST AND AFRICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 96

TABLE 139 MIDDLE EAST AND AFRICA: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 96

TABLE 140 MIDDLE EAST AND AFRICA: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION

TECHNIQUES, 2018-2027 (USD MILLION) 96

TABLE 141 MIDDLE EAST AND AFRICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 97

TABLE 142 MIDDLE EAST AND AFRICA: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 97

TABLE 143 MIDDLE EAST: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 97

TABLE 144 MIDDLE EAST: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 98

TABLE 145 MIDDLE EAST: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 98

TABLE 146 MIDDLE EAST: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 98

TABLE 147 MIDDLE EAST: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 99

TABLE 148 AFRICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2018-2027 (USD MILLION) 99

TABLE 149 AFRICA: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2018-2027 (USD MILLION) 99

TABLE 150 AFRICA: ORGAN PRESERVATION MARKET FOR DYNAMIC COLD STORAGE, BY PRESERVATION TECHNIQUES,

2018-2027 (USD MILLION) 100

TABLE 151 AFRICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2018-2027 (USD MILLION) 100

TABLE 152 AFRICA: ORGAN PRESERVATION MARKET, BY END USER 2018-2027 (USD MILLION) 100

TABLE 153 MAJOR PLAYERS IN THE GLOBAL ORGAN PRESERVATION MARKET 101

TABLE 154 MOST ACTIVE PLAYERS IN THE GLOBAL ORGAN PRESERVATION MARKET 104

TABLE 155 PRODUCT APPROVAL 105

TABLE 156 ACQUISITION 105

TABLE 157 PRODUCT LAUNCH 106

TABLE 158 RESEARCH & DEVELOPMENT EXPENDITURE 2020 106

TABLE 159 TRANSMEDICS GROUP, INC.: PRODUCTS/SERVICES OFFERED 108

TABLE 160 TRANSMEDICS GROUP, INC.: KEY DEVELOPMENTS 109

TABLE 161 BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS/SERVICES OFFERED 111

TABLE 162 CRYOLIFE, INC.: PRODUCTS/SERVICES OFFERED 113

TABLE 163 XVIVO PERFUSION AB: PRODUCTS/SERVICES OFFERED 115

TABLE 164 XVIVO PERFUSION AB: KEY DEVELOPMENTS 115

TABLE 165 ACCORD HEALTHCARE: PRODUCTS/SERVICES OFFERED 117

TABLE 166 DR. FRANZ KÖHLER CHEMIE GMBH: PRODUCTS/SERVICES OFFERED 119

TABLE 167 21ST CENTURY MEDICINE: PRODUCTS/SERVICES OFFERED 121

TABLE 168 BIOLIFE SOLUTIONS INC: PRODUCTS/SERVICES OFFERED 124

TABLE 169 BIOLIFE SOLUTIONS INC: KEY DEVELOPMENTS 124

TABLE 170 SHANGHAI GENEXT MEDICAL TECHNOLOGY: PRODUCTS/SERVICES OFFERED 126

TABLE 171 PARAGONIX TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 128

TABLE 172 WATERS MEDICAL SYSTEMS: PRODUCTS/SERVICES OFFERED 130

LIST OF FIGURES

FIGURE 1 GLOBAL ORGAN PRESERVATION MARKET STRUCTURE 18

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 24

FIGURE 3 MARKET DYNAMICS: GLOBAL ORGAN PRESERVATION MARKET 26

FIGURE 4 DRIVERS: IMPACT ANALYSIS 28

FIGURE 5 RESTRAINT: IMPACT ANALYSIS 28

FIGURE 6 VALUE CHAIN ANALYSIS: ORGAN PRESERVATION MARKET 30

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: ORGAN PRESERVATION MARKET 32

FIGURE 8 GLOBAL ORGAN PRESERVATION MARKET SHARE, BY SOLUTION, 2020 (%) 35

FIGURE 9 GLOBAL: ORGAN PRESERVATION MARKET, BY PRESERVATION TECHNIQUES, 2020 & 2027 (USD MILLION) 41

FIGURE 10 GLOBAL: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2020 & 2027 (USD MILLION) 45

FIGURE 11 GLOBAL: ORGAN PRESERVATION MARKET, BY END USER, 2020 & 2027 (USD MILLION) 49

FIGURE 12 GLOBAL: ORGAN PRESERVATION MARKET, BY REGION 2020 & 2027 (USD MILLION) 52

FIGURE 13 GLOBAL: ORGAN PRESERVATION MARKET SHARE (%), BY REGION, 2020 53

FIGURE 14 AMERICAS: ORGAN PRESERVATION MARKET SHARE, BY REGION 2020 (%) 54

FIGURE 15 NORTH AMERICA: ORGAN PRESERVATION MARKET SHARE, BY COUNTRY 2020 (%) 57

FIGURE 16 EUROPE: ORGAN PRESERVATION MARKET SHARE (%), BY REGION, 2020 65

FIGURE 17 WESTERN EUROPE: ORGAN PRESERVATION MARKET SHARE (%), BY COUNTRY, 2020 68

FIGURE 18 ASIA PACIFIC: ORGAN PRESERVATION MARKET SHARE (%), BY COUNTRY, 2020 83

FIGURE 19 MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET SHARE (%), BY REGION, 2020 95

FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS 102

FIGURE 21 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ORGAN PRESERVATION MARKET 103

FIGURE 22 GLOBAL ORGAN PRESERVATION MARKET: COMPETITIVE LANDSCAPE 104

FIGURE 23 SALES, 2020 106

FIGURE 24 TRANSMEDICS GROUP, INC.: FINANCIAL OVERVIEW SNAPSHOT 108

FIGURE 25 TRANSMEDICS GROUP, INC.: SWOT ANALYSIS 109

FIGURE 26 BRISTOL-MYERS SQUIBB COMPANY: FINANCIAL OVERVIEW SNAPSHOT 110

FIGURE 27 BRISTOL-MYERS SQUIBB COMPANY: SWOT ANALYSIS 111

FIGURE 28 CRYOLIFE, INC.: FINANCIAL OVERVIEW SNAPSHOT 112

FIGURE 29 CRYOLIFE, INC.: SWOT ANALYSIS 113

FIGURE 30 XVIVO PERFUSION AB: FINANCIAL OVERVIEW SNAPSHOT 114

FIGURE 31 XVIVO PERFUSION AB: SWOT ANALYSIS 116

FIGURE 32 ACCORD HEALTHCARE: SWOT ANALYSIS 118

FIGURE 33 DR. FRANZ KÖHLER CHEMIE GMBH: SWOT ANALYSIS 120

FIGURE 34 21ST CENTURY MEDICINE: SWOT ANALYSIS 122

FIGURE 35 BIOLIFE SOLUTIONS INC: FINANCIAL OVERVIEW SNAPSHOT 123

FIGURE 36 BIOLIFE SOLUTIONS INC: SWOT ANALYSIS 125

FIGURE 37 SHANGHAI GENEXT MEDICAL TECHNOLOGY: SWOT ANALYSIS 127

FIGURE 38 PARAGONIX TECHNOLOGIES, INC.: SWOT ANALYSIS 129

FIGURE 39 WATERS MEDICAL SYSTEMS: SWOT ANALYSIS 131